Product logins

Find logins to all Clarivate products below.

home   •  Research Reports  •  DRG Market Assessment Reports

Neuropathic Pain – Current Treatment – Current Treatment: Physician Insights – Neuropathic Pain (US)

Login to access report north_east
Contact sales account_box

The treatment of neuropathic pain involves the use of drugs from several classes, including antidepressants, antiepileptic drugs, local anesthetics, dual-acting opioid analgesics, and opioid analgesics. Despite the increasing availability of generic options across these drug classes, current analgesics fall short in providing adequate relief because of associated side effects, prolonged titration, inadequate dosing, poor compliance, and low treatment satisfaction. The successful launch of a novel analgesic for neuropathic pain will require a granular understanding of treatment patterns in key gateway indications (e.g., postherpetic neuralgia, painful diabetic neuropathy) for emerging neuropathic pain drugs.

QUESTIONS ANSWERED

  • What percentage of neuropathic patients suffer from comorbidities (e.g., depression, insomnia, kidney disease)?
  • How has neurologists’ and PCPs / GPs’ prescribing changed in the past year? What changes are they anticipating in the coming year?
  • How do PCPs / GPs and neurologists differ in their prescribing practices?
  • What nonpharmacological approaches are clinicians using instead of or in addition to prescription drug therapy for neuropathic pain?
  • What are the most common reasons for discontinuation of mainstay drugs for neuropathic pain?
  • What factors most influence treatment initiation for neuropathic pain?

PRODUCT DESCRIPTION

Current Treatment: Physician Insights provides physician insights on treatment dynamics, prescribing behavior, and drivers of brand use so that marketers can create specific messaging around these treatment dynamics to more effectively increase or defend their market position.

Markets covered: United States

Primary research: Survey of 50 U.S. PCPs / GPs and 50 U.S. neurologists fielded in July 2024

Key companies: Pfizer, Scilex, Azurity Pharmaceuticals, Almatica, Grünenthal / Averitas Pharma, Janssen, Assertio Therapeutics, AstraZeneca

Key drugs: Gabapentin, pregabalin, Qutenza, ZTLido, Gralise, Horizant, amitriptyline, duloxetine, venlafaxine, milnacipran, topiramate, NSAIDs, opioids, tramadol, tapentadol

Table of contents

Contact sales account_box
Login to access report north_east

Related Market Assessment Reports

Report
Hepatitis B Virus – Geographic Focus: China – China In-Depth – Hepatitis B Virus
HBV is a major public health burden in China, with chronically infected individuals at a significantly increased risk of developing hepatic cirrhosis and hepatocellular carcinoma. Current treatment…
north_east
Report
Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – Current Treatment – Current Treatment: Physician Insights – B-Cell Non-Hodgkin’s Lymphoma (US)
Non-Hodgkin’s lymphoma (NHL) represents a diverse group of hematological malignancies broadly classified into indolent and aggressive subtypes. Patients with aggressive NHL—diffuse large B-cell…
north_east
Report
Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – Current Treatment – Treatment Sequencing – B-Cell Non-Hodgkin’s Lymphoma (US)
Key benefits and usesPinpoint current drug positioning and uptake in one snapshot to facilitate forecasting.Drill down into physicians’ treatment sequences and understand who to position against…
north_east
Report
Psoriasis – Unmet Need – Unmet Need – Moderate to Severe Psoriasis (US/EU)
Topical therapies are the backbone of psoriasis management; however, they are often inadequate for patients with moderate to severe disease, who typically require systemic treatment. While…
north_east
Report
Major Depressive Disorder (DSM-V) – Current Treatment – Current Treatment: Physician Insights – Major Depressive Disorder (EU5)
Across the EU5, the treatment landscape for major depressive disorder (MDD) is shaped by the widespread use of SSRIs and SNRIs, which continue to serve as firstline therapy due to their…
north_east

Follow us

Contact us

Sales enquiries north_east
Customer service north_east
Support north_east